Mark Rapa

Mark Josef Rapa has a background in law and bioethics, having studied and later taught at the University of Manchester. They are passionate about patient-centred care and have previously worked in patient advocacy, including supporting the introduction of PrEP and improvements to HIV treatment in Malta. Mark participated as a patient in the PROGRESS study, the first large-scale NHS implementation trial of personalised prescribing using pharmacogenomics in primary care. Since then, they have shared their experience at workshops and conferences, helping to bring the patient perspective into how personalised prescribing is designed and delivered